Drug Type Small molecule drug |
Synonyms Biantrazole, Losoxantrone, Losoxantrone hydrochloride (USAN) + [8] |
Target |
Action inhibitors |
Mechanism Top II inhibitors(Topoisomerase II inhibitors), DNA synthesis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Canada (14 Nov 1997), |
Regulation- |
Molecular FormulaC22H29Cl2N5O4 |
InChIKeyXDMHALQMTPSGEA-UHFFFAOYSA-N |
CAS Registry88303-61-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04783 | Losoxantrone hydrochloride | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Breast Cancer | Canada | 14 Nov 1997 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Phase 2 | United States | - | - |
Prostatic Cancer | Phase 2 | Canada | - |